RSA
AGN

Robertson Stephens Advisors’s Allergan plc AGN Stock Holding History

Robertson Stephens Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,400
Closed -$294K – 150
2016
Q4 		$294K Buy
+1,400
New +$290K 0.17% 115

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Robertson Stephens Advisors's AGN Position: Q1 2017 in Review

Robertson Stephens Advisors sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 1,400 shares — an estimated $294K sold.

Robertson Stephens Advisors first reported a position in AGN in Q4 2016 and held it in 1 quarter. The position peaked at $294K in Q4 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Robertson Stephens Advisors reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Robertson Stephens Advisors sold 1,400 Allergan plc shares in Q1 2017, an estimated $294K.
  • Robertson Stephens Advisors first reported a position in Allergan plc in Q4 2016 and held it in 1 quarter.
  • Robertson Stephens Advisors's Allergan plc position peaked at $294K in Q4 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Robertson Stephens Advisors's 13F filing for Q1 2017, filed 12 May 2017.